FDA Rejects MDMA for Mental Health Treatment After Identifying Flawed Study Data
CCHR welcomes the FDA’s decision to disapprove the hallucinogenic drug, MDMA (Ecstasy) saying if approved, it would have fueled a planned $12 billion industry to…
CCHR welcomes the FDA’s decision to disapprove the hallucinogenic drug, MDMA (Ecstasy) saying if approved, it would have fueled a planned $12 billion industry to…
Mental health industry watchdog calls for an end to federal funding for psychedelic drug research on active-duty service members and veterans, likening it to the…
Mental health watchdog says adding psychedelics as approved mental health treatment will fuel more acts of drug-induced violence in the community. By Jan EastgatePresident, CCHR…
A recent national news report on Jack Ruby, who murdered President John F. Kennedy’s assassin, Lee Harvey Oswald, raises questions about the psychiatrist who assessed…
Psychedelics are making a $10 billion-a-year comeback, replacing profit-losing antidepressants; with it comes a new wave of misleading, unproven theories that changing brain chemicals can…